Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldblatt

Showing results (171-180 of 242) with videos related to

Pageof 25
Sort By:
Infection and Immunity|January 25, 2022
Corrected and Republished from: "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal <i>Streptococcus pneumoniae</i> Challenge"Win-Yan Chan, Claire Entwisle, Giuseppe Ercoli, et al.
Infection and Immunity|January 25, 2022
Correction for Chan et al., "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge"Win-Yan Chan, Claire Entwisle, Giuseppe Ercoli, et al.
The Lancet Regional Health. Europe|July 26, 2021
SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort studyKatherine M Gaskell, Marina Johnson, Victoria Gould, et al.
The Journal of Infectious Diseases|June 20, 2022
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine BoosterFarshad Guirakhoo, Shixia Wang, Chang Yi Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2023
Socioeconomic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort StudyTanya Lam, Anja Saso, Arturo Torres Ortiz, et al.
The Lancet. Infectious Diseases|July 10, 2023
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveysKatherine E Gallagher, Ifedayo M O Adetifa, Caroline Mburu, et al.
Brain : a Journal of Neurology|October 7, 2025
Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccinationRoberto Bellanti, Ana Candalija Iserte, Claire Bergstrom Johnson, et al.
Journal of Clinical Microbiology|December 14, 2022
Novel Multilocus Sequence Typing and Global Sequence Clustering Schemes for Characterizing the Population Diversity of Streptococcus mitisAkuzike Kalizang'oma, Brenda Kwambana-Adams, Jia Mun Chan, et al.
Mabs|August 29, 2017
Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomicsAdam S Adler, Rena A Mizrahi, Matthew J Spindler, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharidesCatherine M Wernette, Carl E Frasch, Dace Madore, et al.
Pageof 25

Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Infection and Immunity|January 25, 2022
Corrected and Republished from: "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal <i>Streptococcus pneumoniae</i> Challenge"Win-Yan Chan, Claire Entwisle, Giuseppe Ercoli, et al.
Infection and Immunity|January 25, 2022
Correction for Chan et al., "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge"Win-Yan Chan, Claire Entwisle, Giuseppe Ercoli, et al.
The Lancet Regional Health. Europe|July 26, 2021
SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort studyKatherine M Gaskell, Marina Johnson, Victoria Gould, et al.
The Journal of Infectious Diseases|June 20, 2022
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine BoosterFarshad Guirakhoo, Shixia Wang, Chang Yi Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2023
Socioeconomic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort StudyTanya Lam, Anja Saso, Arturo Torres Ortiz, et al.
The Lancet. Infectious Diseases|July 10, 2023
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveysKatherine E Gallagher, Ifedayo M O Adetifa, Caroline Mburu, et al.
Brain : a Journal of Neurology|October 7, 2025
Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccinationRoberto Bellanti, Ana Candalija Iserte, Claire Bergstrom Johnson, et al.
Journal of Clinical Microbiology|December 14, 2022
Novel Multilocus Sequence Typing and Global Sequence Clustering Schemes for Characterizing the Population Diversity of Streptococcus mitisAkuzike Kalizang'oma, Brenda Kwambana-Adams, Jia Mun Chan, et al.
Mabs|August 29, 2017
Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomicsAdam S Adler, Rena A Mizrahi, Matthew J Spindler, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharidesCatherine M Wernette, Carl E Frasch, Dace Madore, et al.
Pageof 25